International Academy of Compounding… — Receipts Report
Client
Lobbying client · LD-2 disclosures
International Academy of Compounding Pharmacists (Iacp)
Texas
36 filings from 3 registrants · 2008–2018 · latest filed Nov 28, 2018
Reported on its behalf
$3.3M
every LD-2 on file
Its own filed spend
$2.9M
lobbying for itself
Fees to outside firms
$330K
across every firm on file
Spend over time
Every filing period on record, as reported. One column per filed period — a period with no column is a period with no filing, not a zero.
Basis · Amendments and terminations supersede the original report for the same registrant, client and period, so a revised quarter is counted once at its latest filed value. Registration-only filings carry no activity money and are excluded from these totals.
Who lobbies for them
Every outside firm that has filed on this client's behalf, by fees reported.
Sarah Ryan Dodge-PalmerInternational Academy of Compounding Pharmacists (Iacp)Covered position: VP of Government Affairs22 filingsthrough 2013
Cynthia BlankenshipInternational Academy of Compounding Pharmacists (Iacp)Covered position: Legal Fellow to Sen. Lincoln; Counsel to Cong. Walz; Counsel & Sr. Advisor to Cong. Berry16 filingsthrough 2018
This record groups every filed spelling of the client's name into one entity, so "MERCK & CO., INC." and "MERCK & CO INC" read as the same company. The grouping is the client's normalized name — organizations that file under genuinely different names appear separately. Handle: international-academy-of-compounding-pharmacists-iacp.
Reading this · LD-2 reports a hired firm's fee and a registrant's reported expenses on separate lines and never both on one filing, so the two lists above are different quantities and are ranked separately rather than against each other. Firm names link to their own record as the firms chapter lands.
25 filings
$2.9M on those filings
Law Enforcement/Crime/Criminal Justice
LAW
21 filings
$2.5M on those filings
Budget/Appropriations
BUD
11 filings
$1.2M on those filings
Animals
ANI
6 filings
$880K on those filings
Food Industry (safety, labeling, etc.)
FOO
2 filings
$28K on those filings
Medical/Disease Research/Clinical Labs
MED
2 filings
$10K on those filings
Consumer Issues/Safety/Products
CSP
1 filing
$28K on those filings
Trade (domestic/foreign)
TRD
1 filing
Note · A filing names one to several issue areas and reports a single dollar figure for the period, so the same money appears beside every issue that filing declares. The dollar column is therefore spend on filings that named this issue — it is not a split of the total, and these figures sum above it. Filing counts do not double-count.
115th Congress
Preserving Patient Access to Compounded Medications Act of 2017
5 filingsthrough 2018
H.R. 3204114th CongressTEST Act of 20154 filingsthrough 2015
H.Con.Res. 342110th CongressExpressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest.3 filingsthrough 2008
S.Con.Res. 88110th CongressA concurrent resolution expressing the sense of Congress that the Food and Drug Administration's (FDA) new policy restricting women's access to medications containing estriol does not serve the public interest.3 filingsthrough 2008
S. 959113th CongressPharmaceutical Quality, Security, and Accountability Act2 filingsthrough 2013
H.R. 3018111th CongressNamed in the filings; no matching bill record on file.2 filingsthrough 2010
H.R. 970110th CongressDextromethorphan Distribution Act of 20071 filingthrough 2008
S. 1378110th CongressDextromethorphan Distribution Act of 20071 filingthrough 2008
How these are found · Bill references are extracted from the free-text activity description each filing writes, then matched to the Congress in session that filing year. A reference we can't match to a bill on file is still shown, unlinked — we cite what the filing said rather than guess at what it meant. Naming a bill is not a position on it: LD-2 records that a client lobbied on the bill, never which side.
